Assets

Current assets

Cash and cash equivalents

Trade accounts receivable, less allowance for doubtful accounts of $4.7 and $1.3 in 2012 and 2011, respectively

Other accounts receivable

Inventories

Deferred income taxes

Other current assets

Current assets held for sale

Total current assets

Investment in associated companies

Plants, equipment and facilities, at cost

Less: accumulated depreciation

Net plant investment

Acquisition intangibles, net of accumulated amortization of $43.9 and $34.7 in 2012 and 2011, respectively

Goodwill

Deferred income taxes

Other assets

Non-current assets held for sale

Total assets

Liabilities

Current liabilities

Accounts payable

Short-term borrowings

Current maturities on short term debt

Accrued expenses

Income taxes payable

Deferred income taxes

Current liabilities held for sale

Total current liabilities

Long-term debt

Pension and other postretirement benefit liabilities

Other noncurrent liabilities

Deferred income taxes

Non-current liabilities held for sale

Stockholders’ equity

Preferred stock, 20,000,000 shares authorized; none issued and outstanding

Common stock, $.01 par value per share, 150,000,000 shares authorized; issued 49,618,861 in 2012 and 49,586,198 in 2011

Additional paid-in capital

Retained earnings

Accumulated other comprehensive loss

Treasury stock, at cost

Total Cytec Industries Inc. stockholders’ equity

Noncontrolling interests

Total equity

Total liabilities and stockholders’ equity

Receipt of pre-tax net cash proceeds of $1,006.9 from the sale of Coating Resins.

The estimated tax impacts of the transaction.

Repurchase of $550.1 of our common stock under the Board authorized program from October 2012, $62.0 payment of our Revolving Credit Line, and payment of transaction costs.